Uptake and Distribution of Administered Bone Marrow Mesenchymal Stem Cell Extracellular Vesicles in Retina

Cell replacement therapy using mesenchymal (MSC) and other stem cells has been evaluated for diabetic retinopathy and glaucoma. This approach has significant limitations, including few cells integrated, aberrant growth, and surgical complications. Mesenchymal Stem Cell Exosomes/Extracellular Vesicle...

Full description

Bibliographic Details
Main Authors: Biji Mathew, Leianne A. Torres, Lorea Gamboa Acha, Sophie Tran, Alice Liu, Raj Patel, Mohansrinivas Chennakesavalu, Anagha Aneesh, Chun-Chieh Huang, Douglas L. Feinstein, Shafigh Mehraeen, Sriram Ravindran, Steven Roth
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/10/4/730
_version_ 1797540018451906560
author Biji Mathew
Leianne A. Torres
Lorea Gamboa Acha
Sophie Tran
Alice Liu
Raj Patel
Mohansrinivas Chennakesavalu
Anagha Aneesh
Chun-Chieh Huang
Douglas L. Feinstein
Shafigh Mehraeen
Sriram Ravindran
Steven Roth
author_facet Biji Mathew
Leianne A. Torres
Lorea Gamboa Acha
Sophie Tran
Alice Liu
Raj Patel
Mohansrinivas Chennakesavalu
Anagha Aneesh
Chun-Chieh Huang
Douglas L. Feinstein
Shafigh Mehraeen
Sriram Ravindran
Steven Roth
author_sort Biji Mathew
collection DOAJ
description Cell replacement therapy using mesenchymal (MSC) and other stem cells has been evaluated for diabetic retinopathy and glaucoma. This approach has significant limitations, including few cells integrated, aberrant growth, and surgical complications. Mesenchymal Stem Cell Exosomes/Extracellular Vesicles (MSC EVs), which include exosomes and microvesicles, are an emerging alternative, promoting immunomodulation, repair, and regeneration by mediating MSC’s paracrine effects. For the clinical translation of EV therapy, it is important to determine the cellular destination and time course of EV uptake in the retina following administration. Here, we tested the cellular fate of EVs using in vivo rat retinas, ex vivo retinal explant, and primary retinal cells. Intravitreally administered fluorescent EVs were rapidly cleared from the vitreous. Retinal ganglion cells (RGCs) had maximal EV fluorescence at 14 days post administration, and microglia at 7 days. Both in vivo and in the explant model, most EVs were no deeper than the inner nuclear layer. Retinal astrocytes, microglia, and mixed neurons in vitro endocytosed EVs in a dose-dependent manner. Thus, our results indicate that intravitreal EVs are suited for the treatment of retinal diseases affecting the inner retina. Modification of the EV surface should be considered for maintaining EVs in the vitreous for prolonged delivery.
first_indexed 2024-03-10T12:54:05Z
format Article
id doaj.art-490baac648564bd5b95c0da485296da9
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-10T12:54:05Z
publishDate 2021-03-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-490baac648564bd5b95c0da485296da92023-11-21T12:02:17ZengMDPI AGCells2073-44092021-03-0110473010.3390/cells10040730Uptake and Distribution of Administered Bone Marrow Mesenchymal Stem Cell Extracellular Vesicles in RetinaBiji Mathew0Leianne A. Torres1Lorea Gamboa Acha2Sophie Tran3Alice Liu4Raj Patel5Mohansrinivas Chennakesavalu6Anagha Aneesh7Chun-Chieh Huang8Douglas L. Feinstein9Shafigh Mehraeen10Sriram Ravindran11Steven Roth12Department of Anesthesiology, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USADepartment of Anesthesiology, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USADepartment of Anesthesiology, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USADepartment of Anesthesiology, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USADepartment of Anesthesiology, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USADepartment of Anesthesiology, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USADepartment of Anesthesiology, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USADepartment of Anesthesiology, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USADepartment of Oral Biology, College of Dentistry, University of Illinois at Chicago, Chicago, IL 60612, USADepartment of Anesthesiology, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USADepartment of Chemical Engineering, College of Engineering, University of Illinois at Chicago, Chicago, IL 60607, USADepartment of Oral Biology, College of Dentistry, University of Illinois at Chicago, Chicago, IL 60612, USADepartment of Anesthesiology, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USACell replacement therapy using mesenchymal (MSC) and other stem cells has been evaluated for diabetic retinopathy and glaucoma. This approach has significant limitations, including few cells integrated, aberrant growth, and surgical complications. Mesenchymal Stem Cell Exosomes/Extracellular Vesicles (MSC EVs), which include exosomes and microvesicles, are an emerging alternative, promoting immunomodulation, repair, and regeneration by mediating MSC’s paracrine effects. For the clinical translation of EV therapy, it is important to determine the cellular destination and time course of EV uptake in the retina following administration. Here, we tested the cellular fate of EVs using in vivo rat retinas, ex vivo retinal explant, and primary retinal cells. Intravitreally administered fluorescent EVs were rapidly cleared from the vitreous. Retinal ganglion cells (RGCs) had maximal EV fluorescence at 14 days post administration, and microglia at 7 days. Both in vivo and in the explant model, most EVs were no deeper than the inner nuclear layer. Retinal astrocytes, microglia, and mixed neurons in vitro endocytosed EVs in a dose-dependent manner. Thus, our results indicate that intravitreal EVs are suited for the treatment of retinal diseases affecting the inner retina. Modification of the EV surface should be considered for maintaining EVs in the vitreous for prolonged delivery.https://www.mdpi.com/2073-4409/10/4/730astrocytesexosomesextracellular vesiclesin vivo imagingischemiamicroglia
spellingShingle Biji Mathew
Leianne A. Torres
Lorea Gamboa Acha
Sophie Tran
Alice Liu
Raj Patel
Mohansrinivas Chennakesavalu
Anagha Aneesh
Chun-Chieh Huang
Douglas L. Feinstein
Shafigh Mehraeen
Sriram Ravindran
Steven Roth
Uptake and Distribution of Administered Bone Marrow Mesenchymal Stem Cell Extracellular Vesicles in Retina
Cells
astrocytes
exosomes
extracellular vesicles
in vivo imaging
ischemia
microglia
title Uptake and Distribution of Administered Bone Marrow Mesenchymal Stem Cell Extracellular Vesicles in Retina
title_full Uptake and Distribution of Administered Bone Marrow Mesenchymal Stem Cell Extracellular Vesicles in Retina
title_fullStr Uptake and Distribution of Administered Bone Marrow Mesenchymal Stem Cell Extracellular Vesicles in Retina
title_full_unstemmed Uptake and Distribution of Administered Bone Marrow Mesenchymal Stem Cell Extracellular Vesicles in Retina
title_short Uptake and Distribution of Administered Bone Marrow Mesenchymal Stem Cell Extracellular Vesicles in Retina
title_sort uptake and distribution of administered bone marrow mesenchymal stem cell extracellular vesicles in retina
topic astrocytes
exosomes
extracellular vesicles
in vivo imaging
ischemia
microglia
url https://www.mdpi.com/2073-4409/10/4/730
work_keys_str_mv AT bijimathew uptakeanddistributionofadministeredbonemarrowmesenchymalstemcellextracellularvesiclesinretina
AT leianneatorres uptakeanddistributionofadministeredbonemarrowmesenchymalstemcellextracellularvesiclesinretina
AT loreagamboaacha uptakeanddistributionofadministeredbonemarrowmesenchymalstemcellextracellularvesiclesinretina
AT sophietran uptakeanddistributionofadministeredbonemarrowmesenchymalstemcellextracellularvesiclesinretina
AT aliceliu uptakeanddistributionofadministeredbonemarrowmesenchymalstemcellextracellularvesiclesinretina
AT rajpatel uptakeanddistributionofadministeredbonemarrowmesenchymalstemcellextracellularvesiclesinretina
AT mohansrinivaschennakesavalu uptakeanddistributionofadministeredbonemarrowmesenchymalstemcellextracellularvesiclesinretina
AT anaghaaneesh uptakeanddistributionofadministeredbonemarrowmesenchymalstemcellextracellularvesiclesinretina
AT chunchiehhuang uptakeanddistributionofadministeredbonemarrowmesenchymalstemcellextracellularvesiclesinretina
AT douglaslfeinstein uptakeanddistributionofadministeredbonemarrowmesenchymalstemcellextracellularvesiclesinretina
AT shafighmehraeen uptakeanddistributionofadministeredbonemarrowmesenchymalstemcellextracellularvesiclesinretina
AT sriramravindran uptakeanddistributionofadministeredbonemarrowmesenchymalstemcellextracellularvesiclesinretina
AT stevenroth uptakeanddistributionofadministeredbonemarrowmesenchymalstemcellextracellularvesiclesinretina